Overview

Biosurgery Market Introduction

Global Biosurgery Market is predicted to arrive at a value of USD 19.5 billion by the year end of 2027, along with a CAGR of over 6% during the forecast period 2020 to 2027. 

The growth of the geriatric population, coupled with the rise in the sheer number of sports-related injuries and surgeries, the need for adequate patient blood loss management, the increase in the clearance of biosurgery products by regulatory authorities are all factors that have played a role in the potential growth of the market. The market has much economic scope as new products and applications have been introduced. These biosurgery products are found in numerous applications ranging from gynecological surgery, orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, urological surgery, thoracic surgery and reconstructive surgery. 

Based on the segmentation, the market involves products such as surgical sealants and adhesives, soft tissue attachments, staple line reinforcement agents, bone graft substitutes, and hemostatic agents and adhesion barriers. The growing demand for hydrogel-based polymeric sealants has also been instrumental in the meteoric augmentation of the biosurgery market.

The Asia Pacific market region has been anticipated to register a high CAGR value over the forecast time frame. The APAC market is growing rapidly particularly in terms of biosurgery products. It's important to note that the ever-expanding healthcare expenditure, rising need for managing blood loss effectively and the growing number of surgical procedures are factors which have enhanced the market growth in the region. Large networks of key market players as well as the presence of native players and the growing prevalence of biosurgery products, are aspects which have been instrumental to the potential of the market. Therefore, the Asia Pacific region holds a substantial global biosurgery market share.

Key players of the biosurgery industry are Baxter International (US), C.R. Bard (US), Medtronic (Ireland), MAQUET Holding (Germany), CryoLife (US), Stryker Corporation (US), Integra Lifesciences (US), Pfizer (US), and CSL Limited (Australia)Johnson & Johnson (US), Sanofi (France), Cohera Medical (US), Hemostasis (US), B. Braun (Germany). 

Global Biosurgery Market Segmentation:

By Product Type:

• Bone-Graft Substitutes

o Demineralized Bone Matrix

o Synthetic Bone Grafts

o Bone Morphogenetic Proteins

o Other Bone-Graft Substitutes

• Soft-Tissue Attachments 

o Synthetic Meshes

o Biological Meshes

o Allografts

o Xenografts

• Hemostatic Agents 

o Thrombin-Based Hemostatic Agents

o Oxidized Regenerated Cellulose-Based Hemostatic Agents

o Combination Hemostatic Agents

• Surgical Sealants and Adhesives 

• Natural/Biological Sealants and Adhesives

o By Type

1. Fibrin Sealants
2. Collagen-Based Sealants
3. Gelatin-Based Sealants
4. Albumin-Based Sealants
5. Other Natural/Biological Sealants

o By Origin

1. Human Blood-Based Sealants and Adhesives
2. Animal-Based Sealants and Adhesives
3. Synthetic and Semi-Synthetic Sealants and Adhesives
4. Peg Hydrogels
5. Cyanoacrylate-Based Sealants and Adhesives
6. Urethane-Based Sealants and Adhesives
7. Other Synthetic and Semi-Synthetic Sealants and Adhesives

• Adhesion Barriers 

o Synthetic Adhesion Barriers

o Hyaluronic Acid-Based Adhesion Barriers

o Regenerated Cellulose-Based Adhesion Barriers

o Peg-Based Adhesion Barriers

o Thermal Synthetic Adhesion Barriers

o Natural Adhesion Barriers

o Collagen & Protein Adhesion Barriers

o Fibrin-Based Adhesion Barriers

o Staple-Line Reinforcement Agents 

   

By Application:  

• Orthopedic Surgery

• General Surgery

• Neurological Surgery

• Cardiovascular Surgery

• Reconstructive Surgery

• Gynecological Surgery

• Urological Surgery

• Thoracic Surgery 

 

By Region: 

• North America

• Europe

• Asia Pacific

• Latin America

• The Middle East and Africa

 

FutureWise Key Takeaways: 

• Growth prospects

• SWOT analysis

• Key trends

• Key data-points affecting market growth

 

Objectives of the Study:

• To provide with an exhaustive analysis on the global bio surgery market by product type, by application and by region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and the Middle East & Africa

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

 

Table of Contents

1 Biosurgery Market: Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

           1.2.1 Markets Covered

           1.2.2 Years Considered for the Study

    1.3 Currency 

    1.4 Limitations 

    1.5 Stakeholders 

 

2 Biosurgery Market: Research Methodology 

    2.1 Research Data 

           2.1.1 Secondary Data

                    2.1.1.1 Key Data From Secondary Sources

           2.1.2 Primary Data

                    2.1.2.1 Key Data From Primary Sources

                    2.1.2.2 Key Industry Insights

    2.2 Market Size Estimation 

           2.2.1 Bottom-Up Approach

           2.2.2 Top-Down Approach

    2.3 Market Breakdown and Data Triangulation 

    2.4 Assumptions for the Study 

3 Biosurgery Market: Executive Summary 

 

4 Biosurgery Market: Premium Insights

    4.1 Market: Overview 

    4.2 APAC: Market, By Type & Country (2019) 

    4.3 Geographic Snapshot of the Market (2019) 

    4.4 Geographic Mix: Market, 2017 — 2027 (USD Million) 

    4.5 Biosugery Market: Developing vs Developed Markets, 2019 vs 2027 (USD Million) 

 

5 Biosurgery Market: Overview 

    5.1 Introduction 

    5.2 Drivers 

           5.2.1 Rising Geriatric Population

           5.2.2 Increasing Volume of Surgeries and Prevalence of Severe Trauma Injuries

           5.2.3 Strong Focus on R&D Leading to the Launch of New and Advanced Products

           5.2.4 Rising Need for Effective Blood Loss Management in Patients

    5.3 Market Restraints 

           5.3.1 High Price of Biosurgery Products & Rising Cost of Surgical Procedures

    5.4 Opportunities 

           5.4.1 Untapped Emerging Markets

    5.5 Market Challenges 

           5.5.1 Stringent Regulatory Framework

           5.5.2 Requirement of Skilled Personnel for the Effective Use of Biosurgery Products

 

6 Industry Insights 

    6.1 Industry Trends 

           6.1.1 Increasing Market Consolidation

           6.1.2 Rising Focus on Product Developments & Launches

           6.1.3 Growing Demand for Dental Bone-Graft Substitutes

           6.1.4 Growing Preference for Gelatin-Based Adhesives & Hydrogels in Surgical Procedures

    6.2 Regulatory Analysis 

           6.2.1 North America

                    6.2.1.1 US

                    6.2.1.2 Canada

           6.2.2 Europe

           6.2.3 APAC

                    6.2.3.1 Japan

                    6.2.3.2 China

                    6.2.3.3 India

    6.3 Strategic Benchmarking 

           6.3.1 Market: Product Portfolio Analysis

           6.3.2 Natural/Biological Sealants & Adhesives: Product Portfolio Analysis

           6.3.3 Synthetic & Semisynthetic Sealants & Adhesives: Product Portfolio Analysis

           6.3.4 Hemostatic Agents: Product Portfolio Analysis

           6.3.5 Adhesion Barriers: Product Portfolio Analysis

           6.3.6 Soft-Tissue Attachments: Product Portfolio Analysis

           6.3.7 Bone-Graft Substitutes : Product Portfolio Analysis

 

7 Market, By Product 

    7.1 Introduction 

    7.2 Bone-Graft Substitutes 

           7.2.1 Demineralized Bone Matrix

           7.2.2 Synthetic Bone Grafts

           7.2.3 Bone Morphogenetic Proteins

           7.2.4 Other Bone-Graft Substitutes

    7.3 Soft-Tissue Attachments 

           7.3.1 Synthetic Meshes

           7.3.2 Biological Meshes

                    7.3.2.1 Allografts

                    7.3.2.2 Xenografts

    7.4 Hemostatic Agents 

           7.4.1 Thrombin-Based Hemostatic Agents

           7.4.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents

           7.4.3 Combination Hemostatic Agents

    7.5 Surgical Sealants and Adhesives 

           7.5.1 Natural/Biological Sealants and Adhesives

                    7.5.1.1 Natural/Biological Sealants and Adhesives, By Type

                               7.5.1.1.1 Fibrin Sealants

                               7.5.1.1.2 Collagen-Based Sealants

                               7.5.1.1.3 Gelatin-Based Sealants

                               7.5.1.1.4 Albumin-Based Sealants

                               7.5.1.1.5 Other Natural/Biological Sealants

                    7.5.1.2 Natural/Biological Sealants and Adhesives, By Origin

                               7.5.1.2.1 Human Blood-Based Sealants and Adhesives

                               7.5.1.2.2 Animal-Based Sealants and Adhesives

           7.5.2 Synthetic and Semi-Synthetic Sealants and Adhesives

                    7.5.2.1 Peg Hydrogels

                    7.5.2.2 Cyanoacrylate-Based Sealants and Adhesives

                    7.5.2.3 Urethane-Based Sealants and Adhesives

                    7.5.2.4 Other Synthetic and Semi-Synthetic Sealants and Adhesives

    7.6 Adhesion Barriers 

           7.6.1 Synthetic Adhesion Barriers

                    7.6.1.1 Hyaluronic Acid-Based Adhesion Barriers

                    7.6.1.2 Regenerated Cellulose-Based Adhesion Barriers

                    7.6.1.3 Peg-Based Adhesion Barriers

                    7.6.1.4 Ther Synthetic Adhesion Barriers

           7.6.2 Natural Adhesion Barriers

                    7.6.2.1 Collagen & Protein Adhesion Barriers

                    7.6.2.2 Fibrin-Based Adhesion Barriers

    7.7 Staple-Line Reinforcement Agents 

 

8 Market, By Application 

    8.1 Introduction 

    8.2 Orthopedic Surgery 

    8.3 General Surgery 

    8.4 Neurological Surgery 

    8.5 Cardiovascular Surgery 

    8.6 Reconstructive Surgery 

    8.7 Gynecological Surgery 

    8.8 Urological Surgery 

    8.9 Thoracic Surgery 

 

9 Market, By Region 

    9.1 Introduction 

    9.2 North America 

           9.2.1 US

           9.2.2 Canada

    9.3 Europe 

           9.3.1 Germany

           9.3.2 UK

           9.3.3 France

           9.3.4 Italy

           9.3.5 Spain

           9.3.6 Rest of Europe (RoE)

    9.4 Asia Pacific 

           9.4.1 Japan

           9.4.2 China

           9.4.3 India

           9.4.4 Rest of Asia Pacific

    9.5 Latin America 

           9.5.1 Brazil

           9.5.2 Mexico

           9.5.3 Rest of Latin America

    9.6 Middle East and Africa 

 

10 Market: Competitive Landscape 

     10.1 Overview 

     10.2 Market Share Analysis 

             10.2.1 Surgical Sealants and Adhesives

             10.2.2 Hemostatic Agents

             10.2.3 Bone-Graft Substitutes

             10.2.4 Adhesion Barriers

             10.2.5 Soft-Tissue Attachments

     10.3 Competitive Situations and Trends 

             10.3.1 Product Launches and Approvals

             10.3.2 Agreements and Partnerships

             10.3.3 Acquisitions

             10.3.4 Expansions

 

11 Company Profiles 

     11.1 Baxter International, Inc. 

     11.2 B.Braun Melsungen AG 

     11.3 C.R. Bard 

     11.4 Johnson & Johnson 

     11.5 Medtronic, PLC. 

     11.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group) 

     11.7 Cohera Medical Inc. 

     11.8 Integra Lifesciences Holdings Corporation 

     11.9 Commonwealth Serum Laboratories (CSL) 

     11.10 Hemostasis, LLC 

     11.11 Sanofi 

     11.12 Pfizer Inc. 

     11.13 Stryker Corporation 

     11.14 Cryolife, Inc.

Chapter 11 Research Finding and Conclusion 

 

Chapter 12  Research Methodology 

 

Chapter 13  Research Data Source   

 

Tables

Figures